Prescription Symmetry Sequence Analysis Unleashing Its Power in Pharmacovigilance

Prescription Symmetry Sequence Analysis Unleashing Its Power in Pharmacovigilance

Pharmaceutical interventions play a vital role in disease management, yet they can lead to unintended consequences known as adverse drug reactions (ADRs). Pharmacovigilance (PV) systems rely on spontaneous reporting of ADRs as a key strategy to effectively address safety concerns. This method collects real-world data from clinical practice, offering insights distinct from those obtained through controlled clinical trials. Despite its effectiveness, the World Health Organization (WHO) recommends a threshold of over 200 reported cases of ADRs per 1,000,000 population for robust pharmacovigilance. However, a significant challenge in this effort is underreporting, as healthcare professionals may hesitate to report ADRs due to factors such as limited awareness and time constraints. Therefore, in the realm of pharmacovigilance, there’s a constant quest for innovative methods to bolster drug safety oversight. This article delves into one such method: Prescription Symmetry Sequence Analysis (PSSA).

Harnessing the Power of Prescription Symmetry Sequence Analysis

Prescription Symmetry Sequence Analysis is revolutionizing medicine safety signal detection. Traditional methods relied heavily on spontaneous ADR reports, sponsor notifications, or information from international agencies. However, these approaches have limitations. With the availability of extensive administrative health datasets, there’s been a significant shift towards using this data to support PV.

Organizations focusing on drug safety and pharmacovigilance are advancing beyond basic descriptive analysis. They now employ statistical analyses and predictive models to gain deeper insights. By tapping into advanced data analytics capabilities, these companies enhance their ability to anticipate adverse events and develop robust risk evaluation frameworks.

PSSA offers a sophisticated approach, providing new avenues for detecting and responding to potential safety concerns. Its structured methodology allows for more systematic and efficient analysis, contributing to better-informed decision-making in medical safety.

Understanding PSSA: Simplified Overview

Conceptually, PSSA is applied to investigate a scenario where drug B (marker drug) is prescribed to treat an adverse drug event possibly caused by drug A (index drug). For example, the PSSA method was first used to investigate whether beta-blockers (index drug) have depression-provoking effects and lead to an excess risk of being prescribed antidepressants (marker drug). Imagine we’re studying a new medication for high blood pressure. Through PSSA, we notice a pattern: patients who are prescribed this new drug are more likely also to be prescribed medication for stomach ulcers shortly afterwards. This raises a red flag because stomach ulcers can sometimes be a side effect of the blood pressure medication. By spotting this pattern early, we can investigate further and take action to protect patients.

DrugCard Insights: Uncovering Drug Allergies with Prescription Sequence Symmetry Analysis

DrugCard came across a study in medical literature discussing the use of Prescription Sequence Symmetry Analysis to detect drug allergies. Researchers in China conducted a study across multiple medical centers, focusing on patients who received an iodixanol contrast dye. They discovered that some patients experienced allergic reactions to iodixanol. Interestingly, although only a few patients had documented allergies to iodixanol, PSSA suggests that if someone reacts to a drug, they might also receive other allergy medicines. So, the researchers analyzed patient records to look for patterns in the timing of patients receiving iodixanol and other allergy medicines. Statistical analysis identified 22 drugs in 4 categories – calcium preparations, adrenergic/dopaminergic agents, glucocorticoids, and antihistamines – as marker drugs. They found that the likelihood of experiencing a reaction to iodixanol might be much higher than what’s typically reported.

The Role of PSSA in Medication Safety

In conclusion, researchers utilize PSSA as a crucial statistical method to scrutinize medication prescription sequences within a population. Its primary objective is to unearth potential ADRs or drug interactions that might have slipped through the cracks during clinical trials or the pre-marketing phase. PSSA operates by juxtaposing the prescription sequences of a specific medication with those of other medicines within the same population. This method is invaluable for pinpointing rare ADRs or those occurring under specific circumstances. Its reliance on real-world data from extensive population samples over prolonged durations enables comprehensive examination. Consequently, PSSA emerges as a pivotal tool in pharmacovigilance, ensuring continuous medication safety monitoring post-market release.

In leveraging medical big data technology like PSSA to analyze adverse reaction signals post-exposure, a more holistic understanding of real-world adverse reaction rates is achievable, thus advancing the field of pharmacovigilance.

Looking for Expert Guidance?
Our team is on hand round the clock to guide you on how to enhance your literature screening or to offer consultation on your pharmacovigilance processes.
Unlock the Secrets of the Pharma Industry
Get Your Hands on Our Must-Read Business Case Today!
Follow us
Request a demo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Have questuions?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DrugCard has roots in Ukraine. Support all Ukrainians in their fight against russian aggression